TPG Growth Makes Minority Investment in AnovoRx
January 12, 2022
TPG Growth has made a significant minority investment in AnovoRx Holdings, Inc. (Anovo), a specialty pharmacy and patient-support services provider that partners with biopharmaceutical manufacturers to deliver therapies to patients with rare and complex diseases. Financial terms were not disclosed; TPG said the investment will help Anovo expand its service offering, scale operations, and deepen relationships with manufacturer clients and patients.
- Buyers
- TPG Growth (TPG)
- Targets
- AnovoRx Holdings, Inc. (Anovo)
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
GIC and Temasek Acquire Significant Stake in Novotech as TPG Reinvests
March 31, 2025
Healthcare Services
Affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in Novotech, with existing investor TPG Asia reinvesting. The capital will support Novotech's global growth — including expansion in the US, Europe and APAC — and enable further organic investment and transformative M&A.
-
TPG and AmerisourceBergen Acquire OneOncology from General Atlantic
April 20, 2023
Healthcare Services
TPG has agreed to acquire a majority interest in OneOncology and AmerisourceBergen will take a roughly 35% minority stake for approximately $685 million, valuing OneOncology at $2.1 billion. OneOncology's affiliated practices, physicians, and management will retain minority ownership as the parties form a new joint venture; the network includes over 900 affiliated providers across 14 states and the deal is expected to close by the end of September 2023.
-
TPG Completes Majority Investment in iNova Pharmaceuticals
October 31, 2022
Pharmaceuticals
TPG (through its Asia platform) completed a majority investment in iNova Pharmaceuticals, a multinational consumer health and pharmaceutical company, with existing investor Pacific Equity Partners re-investing as a minority co-investor. The deal will support iNova's regional expansion and growth strategy across Southeast and North Asia, and fund channel expansion, product-in-fill and technology investments.
-
Persistence Capital Partners Provides Growth Capital to Anova Fertility & Reproductive Health
June 27, 2019
Healthcare Services
Persistence Capital Partners has partnered with Anova Fertility & Reproductive Health, providing growth capital to accelerate Anova's expansion and capability development. The investment will support opening new clinics, pursuing partnerships and investing in advanced reproductive technologies to scale patient-centric fertility care across Canada.
-
TPG Capital and Vida Ventures Invest $225M in Asklepios BioPharmaceutical (AskBio)
April 11, 2019
Biotechnology
Asklepios BioPharmaceutical (AskBio) raised $235 million in new capital, with TPG Capital and Vida Ventures investing $225 million for a minority stake while AskBio’s founders and board co-invested $10 million. The funding will be used to accelerate clinical development and expand manufacturing capabilities, particularly for AskBio’s AAV gene therapy platform and pipeline.
-
TPG Growth Invests $30M in Solara Active Pharma
February 4, 2019
Pharmaceuticals
TPG Growth will invest $30 million in Solara Active Pharma to support the Indian API manufacturer's growth and capacity expansion into regulated markets. The minority growth equity investment is intended to help Solara scale manufacturing and R&D capabilities and strengthen its position with global generic customers in the US and Europe.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.